Rense.com



Evidence For The Release Of A
Schizophrenia-Causing BioWeapon
From Bob Lee
wolfpsy@hotmail.com
8-3-2



Hi, Jeff...
Two years ago, in 2000, you published this artilcle I sent you:
http://www.rense.com/general3/proges.htm
Later in the year, a study on altered leukocyte gene expression in parturient dairy cows received a 2nd place award for research among graduate students which noted the effects of progesterone on leukocytes.
See the link here: <LINK>
 
Since you published my report in 2000, the following 29 studies relative to progesterone receptors and cancer have been published:
 
1: Chearskul S, Bhothisuwan K, Churintrapun M, Semprasert N, Onreabroi S.
Estrogen receptor-alpha mRNA in primary breast cancer: relationship to estrogen
and progesterone receptor proteins and other prognostic factors.
Asian Pac J Allergy Immunol. 2002 Mar;20(1):13-21.
PMID: 12125913 [PubMed - in process]
 
2: Press M, Spaulding B, Groshen S, Kaminsky D, Hagerty M, Sherman L,
Christensen K, Edwards DP.
Comparison of different antibodies for detection of progesterone receptor in
breast cancer.
Steroids. 2002 Aug;67(9):799-813.
PMID: 12123792 [PubMed - in process]
 
3: Costa SD, Lange S, Klinga K, Merkle E, Kaufmann M.
Factors influencing the prognostic role of oestrogen and progesterone receptor
levels in breast cancer-results of the analysis of 670 patients with 11 years of
follow-up.
Eur J Cancer. 2002 Jul;38(10):1329-34.
PMID: 12091062 [PubMed - in process]
 
4: Fabjani G, Tong D, Czerwenka K, Schuster E, Speiser P, Leodolter S,
Zeillinger R.
Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer
in Austrian women.
Breast Cancer Res Treat. 2002 Mar;72(2):131-7.
PMID: 12038703 [PubMed - in process]
 
5: Jacobsen BM, Richer JK, Schittone SA, Horwitz KB.
New Human Breast Cancer Cells to Study Progesterone Receptor Isoform Ratio
Effects and Ligand-independent Gene Regulation.
J Biol Chem. 2002 Aug 2;277(31):27793-800.
PMID: 12021276 [PubMed - in process]
 
6: Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC,
Chenevix-Trench G.
The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast
cancer in Australian women.
Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):439-43.
PMID: 12010857 [PubMed - indexed for MEDLINE]
 
7: Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog
L, Easton DF.
The pathology of familial breast cancer: predictive value of immunohistochemical
markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients
with mutations in BRCA1 and BRCA2.
J Clin Oncol. 2002 May 1;20(9):2310-8.
PMID: 11981002 [PubMed - indexed for MEDLINE]
 
8: Vienonen A, Syvala H, Miettinen S, Tuohimaa P, Ylikomi T.
Expression of progesterone receptor isoforms A and B is differentially regulated
by estrogen in different breast cancer cell lines.
J Steroid Biochem Mol Biol. 2002 Mar;80(3):307-13.
PMID: 11948015 [PubMed - indexed for MEDLINE]
 
9: Brankovic-Magic M, Jankovic R, Neskovic-Konstantinovic Z,
Nikolic-Vukosavljevic D.
Progesterone receptor status of breast cancer metastases.
J Cancer Res Clin Oncol. 2002 Jan;128(1):55-60.
PMID: 11862473 [PubMed - indexed for MEDLINE]
 
10: Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB.
Differential gene regulation by the two progesterone receptor isoforms in human
breast cancer cells.
J Biol Chem. 2002 Feb 15;277(7):5209-18.
PMID: 11717311 [PubMed - indexed for MEDLINE]
 
11: Runnebaum IB, Wang-Gohrke S, Vesprini D, Kreienberg R, Lynch H, Moslehi R,
Ghadirian P, Weber B, Godwin AK, Risch H, Garber J, Lerman C, Olopade OI,
Foulkes WD, Karlan B, Warner E, Rosen B, Rebbeck T, Tonin P, Dube MP, Kieback
DG, Narod SA.
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2
mutation carriers who were never exposed to oral contraceptives.
Pharmacogenetics. 2001 Oct;11(7):635-8.
PMID: 11668223 [PubMed - indexed for MEDLINE]
 
12: Lin VC, Eng AS, Hen NE, Ng EH, Chowdhury SH.
Effect of progesterone on the invasive properties and tumor growth of
progesterone receptor-transfected breast cancer cells MDA-MB-231.
Clin Cancer Res. 2001 Sep;7(9):2880-6.
PMID: 11555606 [PubMed - indexed for MEDLINE]
 
13: Bonkhoff H, Fixemer T, Hunsicker I, Remberger K.
Progesterone receptor expression in human prostate cancer: correlation with
tumor progression.
Prostate. 2001 Sep 15;48(4):285-91.
PMID: 11536308 [PubMed - indexed for MEDLINE]
 
14: Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW.
Frequency distributions of breast cancer characteristics classified by estrogen
receptor and progesterone receptor status for eight racial/ethnic groups.
Cancer. 2001 Jul 1;92(1):37-45.
PMID: 11443607 [PubMed - indexed for MEDLINE]
 
15: Vyzula R, Zaloudik J, Dusek L, Vermousek I.
Seasonal variation in estrogen and progesterone receptor levels in breast
cancer--a factor in data interpretation.
Neoplasma. 2001;48(1):19-25.
PMID: 11327533 [PubMed - indexed for MEDLINE]
 
16: Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix-Trench G.
No significant association between progesterone receptor exon 4 Val660Leu G/T
polymorphism and risk of ovarian cancer.
Carcinogenesis. 2001 May;22(5):717-21.
PMID: 11323389 [PubMed - indexed for MEDLINE]
 
17: Yoo K, Tajima K, Park S, Kang D, Kim S, Hirose K, Takeuchi T, Miura S.
Postmenopausal obesity as a breast cancer risk factor according to estrogen and
progesterone receptor status (Japan).
Cancer Lett. 2001 Jun 10;167(1):57-63.
PMID: 11323099 [PubMed - indexed for MEDLINE]
 
18: Latil A, Bieche I, Vidaud D, Lidereau R, Berthon P, Cussenot O, Vidaud M.
Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone
receptor expression in human prostate cancer by real-time quantitative reverse
transcription-polymerase chain reaction assays.
Cancer Res. 2001 Mar 1;61(5):1919-26.
PMID: 11280747 [PubMed - indexed for MEDLINE]
 
19: Lohmann C, Gibney E, Cotsonis G, Lawson D, Cohen C.
Progesterone receptor immunohistochemical quantitation compared with cytosolic
assay: correlation with prognosis in breast cancer.
Appl Immunohistochem Mol Morphol. 2001 Mar;9(1):49-53.
PMID: 11277415 [PubMed - indexed for MEDLINE]
 
20: Sasaki M, Dharia A, Oh BR, Tanaka Y, Fujimoto S, Dahiya R.
Progesterone receptor B gene inactivation and CpG hypermethylation in human
uterine endometrial cancer.
Cancer Res. 2001 Jan 1;61(1):97-102.
PMID: 11196205 [PubMed - indexed for MEDLINE]
 
21: Bamberger AM, Milde-Langosch K, Schulte HM, Loning T.
Progesterone receptor isoforms, PR-B and PR-A, in breast cancer: correlations
with clinicopathologic tumor parameters and expression of AP-1 factors.
Horm Res. 2000;54(1):32-7.
PMID: 11182633 [PubMed - indexed for MEDLINE]
 
22: Fazzari A, Catalano MG, Comba A, Becchis M, Raineri M, Frairia R, Fortunati
N.
The control of progesterone receptor expression in MCF-7 breast cancer cells:
effects of estradiol and sex hormone-binding globulin (SHBG).
Mol Cell Endocrinol. 2001 Feb 14;172(1-2):31-6.
PMID: 11165037 [PubMed - indexed for MEDLINE]
 
23: Elledge RM, Green S, Pugh R, Allred DC, Clark GM, Hill J, Ravdin P, Martino
S, Osborne CK.
Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay
compared with ER, PgR and pS2, by immuno-histochemistry in predicting response
to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.
Int J Cancer. 2000 Mar 20;89(2):111-7.
PMID: 10754487 [PubMed - indexed for MEDLINE]
 
24: Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG.
Hormone-related factors and risk of breast cancer in relation to estrogen
receptor and progesterone receptor status.
Am J Epidemiol. 2000 Apr 1;151(7):703-14.
PMID: 10752798 [PubMed - indexed for MEDLINE]
 
25: Klijn JG, Setyono-Han B, Foekens JA.
Progesterone antagonists and progesterone receptor modulators in the treatment
of breast cancer.
Steroids. 2000 Oct-Nov;65(10-11):825-30. Review.
PMID: 11108894 [PubMed - indexed for MEDLINE]
 
26: Desreux J, Kebers F, Noel A, Francart D, Van Cauwenberge H, Heinen V,
Thomas JL, Bernard AM, Paris J, Delansorne R, Foidart JM.
Progesterone receptor activation. an alternative to SERMs in breast cancer.
Eur J Cancer. 2000 Sep;36 Suppl 4:S90-1.
PMID: 11056336 [PubMed - indexed for MEDLINE]
 
27: Shen KL, Yang LS, Hsieh HF, Chen CJ, Yu JC, Tsai NM, Harn HJ.
Microsatellite alterations on human chromosome 11 in in situ and invasive breast
cancer: a microdissection microsatellite analysis and correlation with p53, ER
(estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
J Surg Oncol. 2000 Jun;74(2):100-7.
PMID: 10914818 [PubMed - indexed for MEDLINE]
 
28: Wang-Gohrke S, Chang-Claude J, Becher H, Kieback DG, Runnebaum IB.
Progesterone receptor gene polymorphism is associated with decreased risk for
breast cancer by age 50.
Cancer Res. 2000 May 1;60(9):2348-50.
PMID: 10811106 [PubMed - indexed for MEDLINE]
 
29: Lin VC, Ng EH, Aw SE, Tan MG, Ng EH, Bay BH.
Progesterone induces focal adhesion in breast cancer cells MDA-MB-231
transfected with progesterone receptor complementary DNA.
Mol Endocrinol. 2000 Mar;14(3):348-58.
PMID: 10707953 [PubMed - indexed for MEDLINE]
 
It would seem there is interest in progesterone receptors relative to cancer. There is continued interest in mouse mammary tumor virus and its relationship to HIV/AIDS.
 
To keep you in the forefront of the news in this area, you should be aware that recent research has shown a close relationship between a retrovirus found associated with multiple sclerosis and another retrovirus found associated with schizophrenia. It is also the case that these two retroviruses show relationship to "human endogenous virus type W" as well as to baboon endogenous virus, Mason-Pfizer monkey virus, Woolly Monkey Sarcoma Virus, Gibbon Ape Leukemia Virus, and several mouse leukemia retroviruses including the mouse mammary tumor viruses.
 
It would appear, in examination of the literature relative to these viruses, and, particularly, to the schizophrenia-associated retrovirus, that they are more likely to infect persons with an HLA-DR tissue type than those that don't. It appears that prolactin is the hormone here instead of progesterone. It appears that non-whites are more likely to have HLA-DR tissue type than whites.
I note in the literature that the first isolation of a "virus-like body" associated with
schizophrenia occurred in 1957 in Russia. See this reference:
[Virus-like bodies in the cerebrospinal fluid in schizophrenia.]
MAR GI, SVIADATS AM.
Zh. nevropat. psikhiat., Moskva 1957;57(9):1098-100. Russian.
>From OLDMEDLINE
Why was it not until 2001 that there was evidence of a schizophrenia-associated retrovirus
presented in the literature? See these references:
<LINK>Karlsson H, Bachmann S, Schroder J, McArthur J, Torrey EF, Yolken RH.
Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia.
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4634-9.
PMID: 11296294 [PubMed - indexed for MEDLINE]
 
<LINK>Lewis DA.
Retroviruses and the pathogenesis of schizophrenia.
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4293-4. No abstract available.
PMID: 11296280 [PubMed - indexed for MEDLINE]
 
Note, Jeff, that this "schizophrenia-associated retrovirus" is very similar to baboon endogenous retrovirus, Mason-Pfizer monkey virus, Gibbon Ape
Leukemia Virus, and several of the immunodeficiency-causing Simian Retroviruses that were under study by the Special Virus Cancer Program in
the United States between 1962 and 1978. Note that in 1972, the United States met with and studied the Russian schizophrenia research. See
here:
The 1972 NIMH mission to assess schizophrenic research in the U.S.S.R.
Brown BS, Kopin IJ, Kramer M, Mosher LR, Pollin WN, Salmoiraghi GC, Torrey EF.
Schizophr Bull. 1974;(9):148-153. No Abstract Available.
PMID: 4377469 [PubMed - indexed for MEDLINE]
From PubMed
Interestingly, again, this schizophrenia-associated retrovirus, reported in 2001, above, shows simiarity to baboon endogenous retrovirus, Mason-Pfizer monkey virus, Gibbon Ape leukemia virus, and to the others I have mentioned. HL-23V, the first "human retrovirus" discovered in the 1970s and associated with human leukemia is also closely related to these agents. Here are some early sources on HL-23V: Isolation of a virus closely related to gibbon ape leukaemia virus from cells infected with virus (HL-23V) released by human leukaemic cells.
 
 
Bergholz CM, Wolfe LG, Schulz GA, Deinhardt F, Miller NR, Reitz MS.
J Gen Virol. 1980 May;48(1):111-121. 
PMID: 6247431 [PubMed - indexed for MEDLINE]
>From PubMed
Homology between HL-23V and primate viruses and search for proviral DNA sequences of simian sarcoma associated virus and baboon endogenous virus in DNA from human leukemic cells.
Mishra L, Hong D, Baluda MA.
Leuk Res. 1979;3(5):285-296. No Abstract Available.
PMID: 230394 [PubMed - indexed for MEDLINE]
From PubMed
Oncogenicity of the C-type virus HL-23V in marmosets and characterization of virus isolated from an HL-23V-induced marmoset tumor: comparison with simian sarcoma virus type 1.
Bergholz CM, Wolfe LG, Deinhardt F.
Primates Med. 1978;10:135-141. 
PMID: 205850 [PubMed - indexed for MEDLINE]
From PubMed
Oncogenicity in marmosets of HL-23V, a type C oncornavirus isolated from human leukemic cells, and comparison with simian sarcoma virus type 1 (SSV-1/SSAV-1).
Bergholz CM, Wolfe LG, Deinhardt F, Thakkar B, Marczynska B.
J Natl Cancer Inst. 1977 Apr;58(4):1041-1046. 
PMID: 66319 [PubMed - indexed for MEDLINE]
From PubMed
Detection of integrated type-C viral DNA fragments in two primates (human and gibbon) by the restriction enzyme blotting technique.
Wong-Staal F, Josephs S, Dalla Favera R, Gallo R.
Hamatol Bluttransfus. 1979;23:553-560. 
PMID: 232475 [PubMed - indexed for MEDLINE]
From PubMed
Primate type-C virus nucleic acid sequences (woolly monkey and baboon types) in tissues from a patient with acute myelogenous leukemia and in viruses isolated from cultured cells of the same patient.
Reitz MS, Miller NR, Wong-Staal F, Gallagher RE, Gallo RC, Gillespie DH.
Proc Natl Acad Sci U S A. 1976 Jun;73(6):2113-2117. 
PMID: 59361 [PubMed - indexed for MEDLINE]
From PubMed
Characterisation of a virus (HL23V) isolated from cultured acute myelogenous leukaemic cells.
Chan E, Peters WP, Sweet RW, Ohno T, Kufe DW, Spiegelman S, Gallo RC, Gallagher RE.
Nature. 1976 Mar 18;260(5548):266-268. No Abstract Available.
PMID: 176596 [PubMed - indexed for MEDLINE]
From PubMed
The point I am making with this letter is this. My 2002 report to you concerning progesterone receptors seems to have preceded some substantial research on progesterone receptors and their relationship to cancer. This will continue to expand. Regarding schizophrenia and the retroviral nature of some schizophrenias, I am wondering with your readers WHY, given that there were indications of virus causing schizophrenia in 1957 (found in Russia), given that the schizophrenia-associated retrovirus is very similar to the viruses under study by the Special Virus Cancer Program in the United States between 1962-1978, given that the United States researchers went to Russia and studied Russia's findings on schizophrenia and viruses, that it was near 40 years before the schizophrenia-associated retrovirus gene sequences were "discovered" and finally printed. Why is that? Could it be that the virus associated with schizophrenia is, like the other viruses under study by the Special Virus Cancer Program in the United States between 1962-1978, a virus which interferes with normal immunity from disease? Could it be that the retrovirus associated with schizophrenia was of interest to the MK-NAOMI project of the CIA as it was searching for biological agents that would cause schizophrenia? Could it be that the schizophrenia-associated retrovirus is very like HIV, but is an autoimmune viruses of the brain and not the lymphocytes? It seems this was considered long ago (1978) by the very person who has won a Nobel Prize for studying prion diseases and moved them out of sheep into monkeys. See here:
 
 
 
The possible role of slow virus infection in chronic schizophrenic dementia.
Gajdusek DC.
Birth Defects Orig Artic Ser. 1978;14(5):81-87. No Abstract Available.
PMID: 687800 [PubMed - indexed for MEDLINE]
 
From PubMed
See also the works by EF Torrey:
Slow and latent viruses in schizophrenia.
Torrey EF, Peterson MR.
Lancet. 1973 Jul 7;2(7819):22-24. No Abstract Available.
PMID: 4123294 [PubMed - indexed for MEDLINE]
 
 
 
Jeff, watch for the incidence/prevalence of schizophrenia. Particularly, watch this incidence/prevalence among peoples of color. It is my thought that, like HIV, we have a slow/latent retrovirus loose that can cause schizophrenia in a slowly developing latent infection similar to the actions of HIV. It is my guess that you will see an increase in incidence/prevalence of schizophrenia among peoples of color throughout the world. I am guessing that weaponization of a schizophrenia virus could bring an entirely new dimension to biological warfare. Certainly schizophrenia has been around for thousands of years but a retrovirus was found that could cause schizophrenia and it is a slow, latent virus... and it resembles the viruses that were under study by the Special Virus Cancer Program (SVCP). The SVCP documents (15 annual progress reports) lay out an interesting trail. There was no HIV before this program began... HIV was just beginning to infect the world when this program ended. A word to the wise, Jeff.
 
 
Thanks for your steadfast commitment to tell the truth wherever it may lead.
Robert E. Lee, M.S., M.S.W., L.C.S.W.
Author of AIDS: An Explosion of the Biological Time Bomb?
LINK





MainPage
http://www.rense.com


This Site Served by TheHostPros